Enterprise Hot News

SOLACI SOCIME 2025 | Unlock the Latin American Medical Market and Jointly Build a Global Health Future!

The 2025 Annual Congress of the Latin American Society of Interventional Cardiology (SOLACI SOCIME 2025) was grandly held in Mexico from August 6 to 8. As the most influential cardiovascular intervention event in Latin America, SOLACI brought together experts and scholars in the field of cardiovascular intervention from various countries in Latin America and around the world. They jointly discussed and shared the latest research results and clinical experience, making it an important platform for showcasing cutting-edge technologies in global cardiovascular interventional diagnosis and treatment.

Octoparms® Vena Cava Filter Tanghulu® Balloon MiStent® Coronary Drug-Eluting Stent

Kossel’s Exhibited Products

Octoparms® Vena Cava Filters

In the core exhibition area of this congress, Kossel demonstrated innovative products and professional solutions in the fields of peripheral intervention, coronary intervention, and cardiac electrophysiology. Particularly, its core products that attracted much attention, such as the Octoparms® Vena Cava Filter, Tanghulu® Balloon, and MiStent® Coronary Drug-Eluting Stent, drew the attention of experts and business partners from countries including Mexico, Costa Rica, Panama, Brazil, Peru, and Colombia, who came to observe and communicate.

Octoparms® Vena Cava Filter Tanghulu® Balloon MiStent® Coronary Drug-Eluting Stent

We carefully listened to the suggestions and expectations of visitors regarding Kossel’s products, which provided directions for further improving product performance and developing customized services to meet the specific clinical needs in the Latin American region.

Octoparms® Vena Cava Filter

Tanghulu® Balloon

MiStent® Coronary Drug-Eluting

Through this congress, Kossel further gained insights into the regional national policies, clinical needs, market scale, and other information, and promoted the initiation of local registration. This laid a solid foundation for better serving overseas patients in the Latin American region in the future.

Going forward, Kossel will continue to deepen its presence in the industry, integrate technologies and experiences from top experts around the world, and conduct innovative R&D. With higher-quality products and services, Kossel will empower clinical practice, benefit a large number of patients, and contribute the strength of a Chinese medical device brand to improving the cardiovascular health level in this region!

Share the Post:

Related Posts